Inhibikase Therapeutics (IKT) Invested Capital (2020 - 2025)
Inhibikase Therapeutics' Invested Capital was $172.9 million in Q4 2025, up 82.0% from $94.98 million a year earlier and up 137.2% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Invested Capital (2020 - 2025) Analysis & Trends
From Q4 2020 onward, Inhibikase Therapeutics has reported Invested Capital for 21 quarters.
- Invested Capital shows a five-year compound annual growth rate of 76.5% (FY2020 to FY2025).
- In earlier years, Invested Capital was $94.98 million in FY2024 (+753.5%), $11.13 million in FY2023 (-47.5%), $21.18 million in FY2022 (-45.2%) and $38.66 million in FY2021 (+282.7%).
- The Q4 2025 figure marks the highest quarterly Invested Capital in data going back to Q4 2020.
- Compared with a year earlier, Invested Capital was higher in two of the last four quarters, with growth averaging 172.4%.
- The best year-over-year quarter for Invested Capital over five years was Q4 2024 (growth of 753.5%); the worst was Q2 2024 (a decline of 73.2%).
- Per Business Quant data, IKT's Invested Capital in the three quarters before Q4 2025 was $72.9 million (Q3 2025), $80.09 million (Q2 2025) and $85.81 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Inhibikase Therapeutics | 336.92 Mn | -248.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 172.90 Mn |
| Sep 30, 2025 | 72.90 Mn |
| Jun 30, 2025 | 80.09 Mn |
| Mar 31, 2025 | 85.81 Mn |
| Dec 31, 2024 | 94.98 Mn |
| Sep 30, 2024 | -385,381.00 |
| Jun 30, 2024 | 5.25 Mn |
| Mar 31, 2024 | 6.93 Mn |
| Dec 31, 2023 | 11.13 Mn |
| Sep 30, 2023 | 15.17 Mn |
| Jun 30, 2023 | 19.61 Mn |
| Mar 31, 2023 | 25.43 Mn |
| Dec 31, 2022 | 21.18 Mn |
| Sep 30, 2022 | 25.28 Mn |
| Jun 30, 2022 | 29.50 Mn |
| Mar 31, 2022 | 34.01 Mn |
| Dec 31, 2021 | 38.66 Mn |
| Sep 30, 2021 | 43.41 Mn |
| Jun 30, 2021 | 47.30 Mn |
| Mar 31, 2021 | 9.28 Mn |
API Access
Inhibikase Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();